Cargando…
Strong dose response after immunotherapy with PQ grass using conjunctival provocation testing()
BACKGROUND: Pollinex Quattro Grass (PQ Grass) is an effective, well-tolerated, short pre-seasonal subcutaneous immunotherapy to treat seasonal allergic rhinoconjunctivitis (SAR) due to grass pollen. In this Phase II study, 4 cumulative doses of PQ Grass and placebo were evaluated to determine its op...
Autores principales: | Zielen, S., Kuna, P., Aberer, W., Lassmann, S., Pfaar, O., Klimek, L., Wade, A., Kluehr, K., Raab, J., Wessiepe, D., Lee, D., Kramer, M.F., Gunawardena, K., Higenbottam, T., Heath, M.D., Skinner, M.A., de Kam, P.J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
World Allergy Organization
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831906/ https://www.ncbi.nlm.nih.gov/pubmed/31709029 http://dx.doi.org/10.1016/j.waojou.2019.100075 |
Ejemplares similares
-
Randomized controlled trials define shape of dose response for Pollinex Quattro Birch allergoid immunotherapy
por: Worm, M., et al.
Publicado: (2018) -
Conjunctival Provocation Test With Blomia tropicalis
por: Mourao, Elizabeth Maria Mercer, et al.
Publicado: (2021) -
The conjunctival allergen provocation test and the nasal allergen provocation test as specific alternatives to the oral food challenge
por: Krzych-Fałta, Edyta
Publicado: (2021) -
Validation of AI-based software for objectification of conjunctival provocation test
por: Yarin, Yury, et al.
Publicado: (2023) -
Transcriptome analysis and safety profile of the early-phase clinical response to an adjuvanted grass allergoid immunotherapy
por: Starchenka, Sviatlana, et al.
Publicado: (2019)